Research ArticleDrug Discovery and Translational Medicine
PF-1355, a Mechanism-Based MPO Inhibitor, for the Prevention of Immune-Complex Vasculitis and Anti-GBM Glomerulonephritis
Wei Zheng, Roscoe Warner, Roger B Ruggeri, Chunyan Su, Christian Cortes, Athanasia Skoura, Jessica Ward, Kay Ahn, Amit Kalgutkar, Dexue Sun, Tristan Maurer, Paul Bonin, Carlin Okerberg, Walter Bobrowski, Thomas T Kawabe, Yanwei Zhang, Timothy M Coskran, Sammy Bell, Bhupesh Kapoor, Kent Johnson and Leonard Buckbinder
Journal of Pharmacology and Experimental Therapeutics February 19, 2015, jpet.114.221788; DOI: https://doi.org/10.1124/jpet.114.221788
Wei Zheng
1 Pfizer WRD;
Roscoe Warner
2 University of Michigan;
Roger B Ruggeri
1 Pfizer WRD;
Chunyan Su
1 Pfizer WRD;
Christian Cortes
1 Pfizer WRD;
Athanasia Skoura
1 Pfizer WRD;
Jessica Ward
1 Pfizer WRD;
Kay Ahn
3 Pfizer, Inc;
Amit Kalgutkar
4 Pfizer Worldwide Research and Development;
Dexue Sun
1 Pfizer WRD;
Tristan Maurer
5 Pfizer Inc.;
Paul Bonin
1 Pfizer WRD;
Carlin Okerberg
6 Pfizer WRDb
Walter Bobrowski
1 Pfizer WRD;
Thomas T Kawabe
1 Pfizer WRD;
Yanwei Zhang
1 Pfizer WRD;
Timothy M Coskran
1 Pfizer WRD;
Sammy Bell
1 Pfizer WRD;
Bhupesh Kapoor
1 Pfizer WRD;
Kent Johnson
2 University of Michigan;
Leonard Buckbinder
1 Pfizer WRD;
Data Supplement
Files in this Data Supplement:
- Supplemental Data - supplemental methods, results, 4 tables, and 6 figures.